西北药学杂志
西北藥學雜誌
서북약학잡지
2014年
2期
173-177
,共5页
贺鑫韬%马桂芝%滕亮%马文娜
賀鑫韜%馬桂芝%滕亮%馬文娜
하흠도%마계지%등량%마문나
左旋多巴微囊胃内漂浮片%高效液相色谱法%药物动力学
左鏇多巴微囊胃內漂浮片%高效液相色譜法%藥物動力學
좌선다파미낭위내표부편%고효액상색보법%약물동역학
Levodopa Microcapsules Intragastric Floating Tablets%HPLC%pharmacokinetics
目的:建立左旋多巴微囊胃内漂浮片在比格犬体内的血药质量浓度的测定方法,并对其体内药动学行为进行研究。方法建立HPLC法测定血样中左旋多巴的质量浓度,流动相为水-甲醇(95∶5),其中水相含EDTA 0.08 mmol · L -1、磷酸二氢钾70 mmol · L -1、庚烷磺酸钠2.08 mmol · L -1,流速为0.5 mL · min-1,荧光检测,激发波长278 nm ,发射波长325 nm。6只Bea-g le犬分别给予复方左旋多巴微囊胃内漂浮片,并在给药后多点前肢静脉采血。用该方法检测血浆中左旋多巴的质量浓度,用3P97计算药动学参数。结果该方法的线性范围为0.078~20μg · mL -1,最低定量限为0.078μg · mL -1,日内RSD<8.10%,日间RSD<13.52%,回收率为105.1%~113.9%。左旋多巴微囊胃内漂浮片在犬体内的药时曲线符合单室模型,主要药物动力学参数分别为 t1/2(1.09±0.46)h,tmax(1.32±0.54)h,Cmax(1.33±0.31)μg· mL-1;AUC为(3.31±1.26)μg·h·mL -1。结论该方法简单、快速,可用于比格犬的左旋多巴血药质量浓度的测定和药动学研究。
目的:建立左鏇多巴微囊胃內漂浮片在比格犬體內的血藥質量濃度的測定方法,併對其體內藥動學行為進行研究。方法建立HPLC法測定血樣中左鏇多巴的質量濃度,流動相為水-甲醇(95∶5),其中水相含EDTA 0.08 mmol · L -1、燐痠二氫鉀70 mmol · L -1、庚烷磺痠鈉2.08 mmol · L -1,流速為0.5 mL · min-1,熒光檢測,激髮波長278 nm ,髮射波長325 nm。6隻Bea-g le犬分彆給予複方左鏇多巴微囊胃內漂浮片,併在給藥後多點前肢靜脈採血。用該方法檢測血漿中左鏇多巴的質量濃度,用3P97計算藥動學參數。結果該方法的線性範圍為0.078~20μg · mL -1,最低定量限為0.078μg · mL -1,日內RSD<8.10%,日間RSD<13.52%,迴收率為105.1%~113.9%。左鏇多巴微囊胃內漂浮片在犬體內的藥時麯線符閤單室模型,主要藥物動力學參數分彆為 t1/2(1.09±0.46)h,tmax(1.32±0.54)h,Cmax(1.33±0.31)μg· mL-1;AUC為(3.31±1.26)μg·h·mL -1。結論該方法簡單、快速,可用于比格犬的左鏇多巴血藥質量濃度的測定和藥動學研究。
목적:건립좌선다파미낭위내표부편재비격견체내적혈약질량농도적측정방법,병대기체내약동학행위진행연구。방법건립HPLC법측정혈양중좌선다파적질량농도,류동상위수-갑순(95∶5),기중수상함EDTA 0.08 mmol · L -1、린산이경갑70 mmol · L -1、경완광산납2.08 mmol · L -1,류속위0.5 mL · min-1,형광검측,격발파장278 nm ,발사파장325 nm。6지Bea-g le견분별급여복방좌선다파미낭위내표부편,병재급약후다점전지정맥채혈。용해방법검측혈장중좌선다파적질량농도,용3P97계산약동학삼수。결과해방법적선성범위위0.078~20μg · mL -1,최저정량한위0.078μg · mL -1,일내RSD<8.10%,일간RSD<13.52%,회수솔위105.1%~113.9%。좌선다파미낭위내표부편재견체내적약시곡선부합단실모형,주요약물동역학삼수분별위 t1/2(1.09±0.46)h,tmax(1.32±0.54)h,Cmax(1.33±0.31)μg· mL-1;AUC위(3.31±1.26)μg·h·mL -1。결론해방법간단、쾌속,가용우비격견적좌선다파혈약질량농도적측정화약동학연구。
Objective To explore the plasma concentration measurement method and to study the pharmacokinetic profiles of Levo-dopa Microcapsules Intragastric Floating Tablets in Beagle dogs .Methods An HPLC method was developed to determine the con-tent of levodopa in the blood samples from Beagle dogs .The mobile phase was consisted of water and methanol(95∶5) ,containing EDTA 0 .08 mmol · L -1 ,potassium dihydrogen phosphate 70 mmol · L -1 ,and heptane sulfonate 2 .08 mmol · L -1 .The flow rate of mobile phase was 0 .5 mL · min-1 .The excitation wavelength of fluorescence detection was 278 nm ,and the emission wave-length of fluorescence detection was 325 nm .Six Beagle dogs were given Levodopa Microcapsules Intragastric Floating Tablets ,and the blood from the forelimb vein were collected at different time after administration .According to the result of concentration of levodopa in plasma ,pharmacokinetic parameters were calculated with 3P97 software .Results The linear range was 0 .078-20μg · mL -1 .The minimum detection limit was 0 .078 μg · mL -1 .The RSD of within-day was below 8 .10% ,and the RSD of be-tween-days was below 13 .52% .The recovery was between 105 .1%-113 .9% .The concentration-time curve of Levodopa Microcap-sules Intragastric Floating Tablets fitted to one-compartment model .The main pharmacokinetic parameters of Levodopa Microcap-sules Intragastric Floating Tablets was t1/2 (1 .09 ± 0 .46) h ,tmax (1 .32 ± 0 .54) h ,Cmax (1 .33 ± 0 .31)μg · mL -1 ,and AUC (3 .31 ± 1.26)μg · h · mL -1 .Conclusion The method was simple and rapid ,which can be used to determine the levodopa plasma con-centration and study the pharmacokinetic profiles .